$RXMD - Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in China BY GlobeNewswire — 7:00 AM ET 02/02/2022 Miami, FL, Feb. 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. ( RXMD Loading... Loading... ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, is pleased to announce that its PharmcoRx subsidiary’s gained status as one of the 35 approved COVID-19 test vendors in the U.S. for travel to the People’s Republic of China (“China”), for the Beijing Winter Olympic Games.
Alan Jay Weisberg, Chairman and Chief Executive Officer of Progressive Care ( RXMD Loading... Loading... ), commented, “With the upcoming start of the Olympic Games in Beijing, China, we are honored to have been one of the selected vendors for COVID-19 testing of U.S. travelers bound for China. We believe our timeliness, accuracy, and service differentiate us from other Covid-19 test vendors and were the basis of our selection.”
Progressive Care, Inc. ( RXMD Loading... Loading... )
Progressive Care, Inc. ( RXMD Loading... Loading... ) , through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
For more information about Progressive Care ( RXMD Loading... Loading... ), please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc. ( RXMD Loading... Loading... )
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.